ORIGINAL RESEARCH article
Front. Neurol.
Sec. Stroke
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1613701
Size of affected vessels in primary angiitis of the CNS: associations with clinical features, medical management and functional outcomes
Provisionally accepted
- 1Goethe University Frankfurt, Frankfurt, Hesse, Germany
- 2Charité University Medicine Berlin, Berlin, Baden-Wurttemberg, Germany
- 3University of Kiel, Kiel, Germany
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Primary angiitis of the central nervous system (PACNS) presents with heterogeneous clinical manifestations. Since implications of specific patterns of vessel size involvement are not well elucidated, this study aimed to investigate individual disease courses by involved vessel calibers and systematically assess clinical outcomes, relapses, and demographic data. Methods: This single-center retrospective study (January 2010–April 2022) included 105 cerebral vasculitis patients. PACNS cases (n=49) were stratified into four groups based on radiological vessel involvement: large vessels (Group 1), large and medium-sized vessels (Group 2), small/peripheral vessels (Group 3), and mixed vessel involvement (Group 4). Data on demographics, risk factors, imaging findings, and clinical outcomes were analyzed. Results: Among 49 PACNS patients (53.1% female, mean age 46.8 years), cardiovascular risk factors, specifically body weight (p=0.021), showed significant differences between groups. Biopsies were positive exclusively in cases with small vessel involvement across all groups (n = 9). Cyclophosphamide usage was higher in patients with small vessel involvement (p<0.05). Patients with exclusive small vessel involvement showed greater functional decline (p=0.002 for 2nd relapse), more severe imaging progression (p=0.012 for 3rd relapse) and a trend towards more relapses overall compared to groups without small vessel involvement. Conclusions: Despite a limited sample size due to the rarity of the disease, our study highlights vessel size as a key factor in PACNS heterogeneity, associating small vessel involvement with worse functional outcomes, greater imaging progression, and distinct treatment patterns. These findings underscore the importance of vessel size in understanding PACNS pathophysiology and guiding management.
Keywords: Cerebral vasculitis, Immunosuppression, Vessel caliber, cerebral ischemia, prognosis
Received: 17 Apr 2025; Accepted: 02 Sep 2025.
Copyright: © 2025 Frank, Jacques, Deb-Chatterji and Seiler. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Alexander Seiler, University of Kiel, Kiel, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.